Translations:Medication/15/en: Difference between revisions

From Azupedia
Jump to navigation Jump to search
VisualWikitext
FuzzyBot (talk | contribs)
15,166 edits
Importing a new version from external source
 
(No difference)

Latest revision as of 09:47, 22 January 2023

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (Medication)
{{main|Drug class}}
One of the key classifications is between traditional [[small molecule|small molecule]] drugs; usually derived from chemical synthesis, and [[biologic medical product|biologic medical product]]s; which include [[recombinant proteins|recombinant proteins]], [[vaccines|vaccines]], [[blood products|blood products]] used therapeutically (such as [[IVIG|IVIG]]), [[gene therapy|gene therapy]], and [[cell therapy|cell therapy]] (for instance, [[stem cell|stem cell]] therapies).
Main article: Drug class

One of the key classifications is between traditional small molecule drugs; usually derived from chemical synthesis, and biologic medical products; which include recombinant proteins, vaccines, blood products used therapeutically (such as IVIG), gene therapy, and cell therapy (for instance, stem cell therapies).

Retrieved from "https://wiki.tiffa.net/w/index.php?title=Translations:Medication/15/en&oldid=3969"